6De Bosscher K, Vanden Berghe W, Haegeman G. The interplay between the glucocorticoid receptor and nuelear faclor-kappaB or activator protein-1: molecular mechanisms for gene repression. Enaoer Revery,2003,24:488-522.
7Hansen M,Podenphant J,Florescu A, et al. A randomized trim of differentiated prednisolone treatment in acive rheumatoid arthritis: elinical benefits and skeletat side effecls. Ann Rheum Dis, 1999, 58:713-718.
8Landewe RB, Boers M, Verhoeven AC, et al. COBRA combination therapy in patients with early rheumatoid arthritis:long-term structural benefits of a brief intervention. Arhritis Rheum, 2002,46 : 347-356.
9Capell HA, Madhok R, Hunter JA, et al. Lack of radiotogical and elinical benefil over two years of low dose prednisolone for rheumatoid arthritis:results of a randomized controlled triM. Ann Rheum Dia,2004,63:797-803.
10[1]Saag KG,Criswell LA,Sems KM,et al.Low-dose corticosteroids in rheumatoid arthritis.A meta-analysis of their moderate-term effectiveness.Arthritis Rheum,1996,39 (11):1818 -1825.
